welcome to DuchenneXchange
- a positively charged Duchenne muscular dystrophy community.- join today!
- log in
Abstracts & Posters
P4.1 Puberty is delayed or absent in Duchenne Muscular Dystrophy boys on chronic glucocorticoid therapy
source: Neuromuscular Disorders
year: 2011
authors: M.M. Rutter, S.R. Rose, J. Collins, H. Sucherew, B.L. Wong, I. Rybalsky
summary/abstract:Chronic glucocorticoids (GCs) are standard therapy and slow disease progression in Duchenne Muscular Dystrophy (DMD). However, GCs cause adverse endocrine effects, including pubertal delay, growth failure and osteoporosis. Absent/delayed puberty is an important problem in DMD which, in turn, negatively impacts bone health, growth, self esteem and muscle strength. The prevalence in DMD is unknown, and it is frequently under-recognized and untreated.
The objective is to determine the prevalence of absent /delayed puberty in DMD boys on GC therapy.
organization: Cincinnati Children’s Hospital Medical Center, USADOI: 10.1016/j.nmd.2011.06.966
read more
rareRelated
-
Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRSObjective: To evaluate the effects of c...
-
Learning Problems and Behavior in Duchennehttps://www.youtube.com/watch?v=rkbV8qsi...
-
Spironolactone Versus Prednisolone in DMDThis is a randomized, open-label, pilot ...
-
Growth Hormone Increases Bone Toughness and Decreases Muscle Inflammation in Glucocorticoid-Treated Mdx Mice, Model ...The absence of functional dystrophin wit...
-
Steroids for Those with DuchenneCorticosteroids are prescribed for multi...
-
Weekend Steroids and Exercise as Therapy for DMDThe study team will determine the potent...
-
Developing standardized corticosteroid treatment for Duchenne muscular dystrophyDespite corticosteroids being the only t...
